REGENERX BIOPHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2023 was -$385K, a 9.17% increase year-over-year.
  • Regenerx Biopharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2023 was -$1.69M, a 2.83% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$1.73M, a 8.12% decline from 2021.
  • Regenerx Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$1.6M, a 4.88% decline from 2020.
  • Regenerx Biopharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2020 was -$1.52M, a 8.48% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$1.69M -$385K +$38.9K +9.17% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$1.73M -$391K +$58.7K +13.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-04-11
Q3 2022 -$1.79M -$367K +$63.3K +14.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$1.85M -$546K -$207K -61.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-11-14
Q1 2022 -$1.64M -$424K -$44.4K -11.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$1.6M -$450K -$81.7K -22.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-11
Q3 2021 -$1.52M -$430K -$97.2K -29.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$1.42M -$339K +$97.5K +22.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$1.52M -$380K +$7.04K +1.82% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$1.52M -$368K -$18.4K -5.28% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$1.5M -$333K +$1.31K +0.39% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.51M -$436K -$47.7K -12.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$1.46M -$387K -$54.3K -16.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
Q4 2019 -$1.4M -$349K -$85.6K -32.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$1.32M -$334K +$42.1K +11.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$1.36M -$388K -$20.6K -5.59% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$1.34M -$332K +$653K +66.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$1.99M -$264K -$1.68M -119% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$312K -$376K +$983K +72.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$1.29M -$368K -$486K -411% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-14
Q1 2018 -$809K -$986K -$1.1M -1002% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-14
Q4 2017 $286K $1.42M +$995K +236% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-29
Q3 2017 -$709K -$1.36M -$2.22M -258% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.51M $118K -$2.21M -94.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $3.72M $109K +$3.49M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $229K $422K +$1.08M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$853K $862K +$1.99M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$2.84M $2.32M +$4.09M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$6.93M -$3.38M -$1.66M -96.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$5.27M -$660K -$127K -23.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-29
Q3 2015 -$5.14M -$1.13M -$1.25M -1015% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$3.89M -$1.76M -$1.54M -705% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-22
Q1 2015 -$2.35M -$1.72M +$406K +19.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$2.75M -$533K -$524K -5858% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-11
Q3 2014 -$2.23M $123K +$223K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$2.45M -$219K +$11.4K +4.95% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 -$2.46M -$2.13M -$1.79M -539% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$671K -$8.95K +$88.9K +90.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$760K -$99.8K -$5.31K -5.62% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$755K -$230K -$4.49K -1.99% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$750K -$332K +$96.5K +22.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$847K -$97.9K +$763K +88.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-04
Q3 2012 -$1.61M -$94.5K +$1.92M +95.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$3.53M -$226K +$1.31M +85.3% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$4.84M -$429K +$1.17M +73.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$6.01M -$861K Oct 1, 2011 Dec 31, 2011 10-K 2013-04-16
Q3 2011 -$2.02M -$430K -27.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.53M -$162K -11.8% Mar 31, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$1.59M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.37M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.